BioCentury
ARTICLE | Company News

Algonomics, Genmab deal

February 11, 2008 8:00 AM UTC

AlgoNomics will use its antibody structure database and Tripole protein modeling technology to assist in the structural analysis of Genmab's antibody scaffolds, including its UniBody technology. AlgoN...